Fund Holdings — Fairmount Funds Management LLC

Total Portfolio Value
$1.11B
Total Bought
$258.32M
Total Sold
$8.85M
Net Transaction
+$249.47M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
COGENT BIOSCIENCES INC(COGT)6,225,6419,003,418+2,777,77744,700129,28911.63%+84,589
DIANTHUS THERAPEUTICS INC(DNTH)2,707,1913,307,191+600,00050,435130,13811.71%+79,703
ABIVAX SA(ABVX)0713,434+713,434060,5715.45%+60,571
ORUKA THERAPEUTICS INC(ORKA)3,371,9223,705,262+333,34037,79971,2526.41%+33,453
VIRIDIAN THERAPEUTICS INC(VRDN)3,459,9133,459,913048,37074,6656.72%+26,295
ZENAS BIOPHARMA INC(ZBIO)1,892,8061,892,806018,34142,0203.78%+23,679
KINIKSA PHARMACEUTICALS INTL(KNSA)1,772,8391,772,839049,05468,8396.19%+19,785
AXSOME THERAPEUTICS INC(AXSM)815,176815,176085,09699,0038.91%+13,907
NUVALENT INC727,563727,563055,51362,9205.66%+7,407
SPYRE THERAPEUTICS INC(SYRE)4,018,1014,018,101060,15167,3436.06%+7,192
ASTRIA THERAPEUTICS INC3,554,1293,554,129019,05025,8742.33%+6,824
SCHOLAR ROCK HLDG CORP(SRRK)1,824,0311,824,031064,60767,9276.11%+3,320
ENLIVEN THERAPEUTICS INC3,711,4443,711,444074,45275,9736.84%+1,522
INHIBIKASE THERAPEUTICS INC(IKT)6,125,0006,125,000011,9449,9230.89%-2,021
JADE BIOSCIENCES INC3,220,3683,220,368032,17127,7922.50%-4,380
CRESCENT BIOPHARMA INC.(CBIO)1,387,8661,387,866022,40016,5021.48%-5,898
APOGEE THERAPEUTICS INC(APGE)2,048,6472,048,647088,97381,3937.32%-7,580
CYTOMX THERAPEUTICS INC(CTMX)3,896,5820-3,896,5828,8450—-8,845
Page 1 of 1